Compare IOVA & LFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IOVA | LFST |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.6M | 2.8B |
| IPO Year | N/A | 2021 |
| Metric | IOVA | LFST |
|---|---|---|
| Price | $2.54 | $7.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $10.45 | $8.83 |
| AVG Volume (30 Days) | ★ 12.2M | 2.4M |
| Earning Date | 02-26-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $250,425,000.00 | ★ $1,367,570,000.00 |
| Revenue This Year | $60.71 | $15.75 |
| Revenue Next Year | $59.52 | $14.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 175.62 | 13.39 |
| 52 Week Low | $1.64 | $3.74 |
| 52 Week High | $7.78 | $8.30 |
| Indicator | IOVA | LFST |
|---|---|---|
| Relative Strength Index (RSI) | 53.00 | 71.65 |
| Support Level | $2.69 | $6.77 |
| Resistance Level | $2.89 | $7.19 |
| Average True Range (ATR) | 0.20 | 0.18 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 54.40 | 98.11 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.